US Stock MarketDetailed Quotes

Syndax Pharmaceuticals (SNDX)

Watchlist
  • 20.790
  • +0.270+1.32%
Close Jan 22 16:00 ET
  • 20.799
  • +0.009+0.04%
Post 19:26 ET
1.81BMarket Cap-5.78P/E (TTM)

Syndax Pharmaceuticals (SNDX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
266.97%45.87M
984.51%37.96M
20.04M
23.68M
7.68M
12.5M
3.5M
0
0
0
Operating revenue
266.97%45.87M
984.51%37.96M
--20.04M
--23.68M
--7.68M
--12.5M
--3.5M
--0
--0
--0
Cost of revenue
2.1M
1.28M
885K
826K
826K
0
0
0
0
Gross profit
250.17%43.77M
947.97%36.68M
19.16M
22.85M
6.85M
12.5M
3.5M
0
0
Operating expense
-0.86%101.2M
36.44%106.03M
29.43%102.91M
57.65%362.53M
32.49%103.22M
81.13%102.08M
56.44%77.72M
72.80%79.51M
51.53%229.95M
85.34%77.91M
Selling and administrative expenses
44.40%44.92M
50.73%43.81M
78.23%41.03M
80.63%120.88M
65.46%37.69M
80.14%31.11M
94.86%29.06M
92.48%23.02M
101.22%66.92M
123.50%22.78M
-General and administrative expense
44.40%44.92M
50.73%43.81M
78.23%41.03M
80.63%120.88M
65.46%37.69M
80.14%31.11M
94.86%29.06M
92.48%23.02M
--66.92M
--22.78M
Research and development costs
-20.70%56.28M
27.89%62.23M
9.11%61.64M
48.22%241.65M
18.87%65.53M
81.57%70.97M
39.96%48.66M
65.89%56.49M
37.58%163.03M
73.13%55.13M
Other operating expenses
----
----
--247K
----
----
----
----
----
----
----
Operating profit
35.89%-57.43M
6.55%-69.35M
-5.34%-83.76M
-47.71%-339.67M
-23.70%-96.37M
-58.95%-89.58M
-49.39%-74.22M
-72.80%-79.51M
-51.53%-229.95M
-85.34%-77.91M
Net non-operating interest income expense
-155.62%-3.01M
-130.58%-1.91M
-112.05%-868K
0.98%21.16M
-58.05%2.3M
2.73%5.42M
21.00%6.24M
42.99%7.2M
666.18%20.96M
86.32%5.49M
Non-operating interest income
-3.18%5.27M
-5.32%5.95M
-1.01%7.18M
23.28%26.09M
28.07%7.11M
1.81%5.44M
21.06%6.28M
42.95%7.26M
260.41%21.16M
85.74%5.55M
Non-operating interest expense
35,913.04%8.28M
17,362.22%7.86M
14,538.18%8.05M
2,269.71%4.93M
7,528.57%4.81M
-67.14%23K
28.57%45K
37.50%55K
-93.37%208K
46.51%63K
Other net income (expense)
-959.38%-275K
-581.40%-586K
-154.02%-221K
31.58%-247K
-92.73%-106K
148.48%32K
7.53%-86K
40.82%-87K
-14.24%-361K
48.11%-55K
Other non- operating income (expenses)
-959.38%-275K
-581.40%-586K
-154.02%-221K
31.58%-247K
-92.73%-106K
148.48%32K
7.53%-86K
40.82%-87K
-14.24%-361K
48.11%-55K
Income before tax
27.83%-60.72M
-5.56%-71.85M
-17.19%-84.85M
-52.25%-318.76M
-29.94%-94.17M
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
Income tax
Net income
27.83%-60.72M
-5.56%-71.85M
-17.19%-84.85M
-52.25%-318.76M
-29.94%-94.17M
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
Net income continuous Operations
27.83%-60.72M
-5.56%-71.85M
-17.19%-84.85M
-52.25%-318.76M
-29.94%-94.17M
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
Minority interest income
Net income attributable to the parent company
27.83%-60.72M
-5.56%-71.85M
-17.19%-84.85M
-52.25%-318.76M
-29.94%-94.17M
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.83%-60.72M
-5.56%-71.85M
-17.19%-84.85M
-52.25%-318.76M
-29.94%-94.17M
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
Basic earnings per share
28.57%-0.7
-3.75%-0.83
-15.29%-0.98
-24.83%-3.72
-10.00%-1.1
-34.25%-0.98
-25.00%-0.8
-44.07%-0.85
-21.14%-2.98
-61.29%-1
Diluted earnings per share
28.57%-0.7
-3.75%-0.83
-15.29%-0.98
-24.83%-3.72
-10.00%-1.1
-34.25%-0.98
-25.00%-0.8
-44.07%-0.85
-21.14%-2.98
-61.29%-1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 266.97%45.87M984.51%37.96M20.04M23.68M7.68M12.5M3.5M000
Operating revenue 266.97%45.87M984.51%37.96M--20.04M--23.68M--7.68M--12.5M--3.5M--0--0--0
Cost of revenue 2.1M1.28M885K826K826K0000
Gross profit 250.17%43.77M947.97%36.68M19.16M22.85M6.85M12.5M3.5M00
Operating expense -0.86%101.2M36.44%106.03M29.43%102.91M57.65%362.53M32.49%103.22M81.13%102.08M56.44%77.72M72.80%79.51M51.53%229.95M85.34%77.91M
Selling and administrative expenses 44.40%44.92M50.73%43.81M78.23%41.03M80.63%120.88M65.46%37.69M80.14%31.11M94.86%29.06M92.48%23.02M101.22%66.92M123.50%22.78M
-General and administrative expense 44.40%44.92M50.73%43.81M78.23%41.03M80.63%120.88M65.46%37.69M80.14%31.11M94.86%29.06M92.48%23.02M--66.92M--22.78M
Research and development costs -20.70%56.28M27.89%62.23M9.11%61.64M48.22%241.65M18.87%65.53M81.57%70.97M39.96%48.66M65.89%56.49M37.58%163.03M73.13%55.13M
Other operating expenses ----------247K----------------------------
Operating profit 35.89%-57.43M6.55%-69.35M-5.34%-83.76M-47.71%-339.67M-23.70%-96.37M-58.95%-89.58M-49.39%-74.22M-72.80%-79.51M-51.53%-229.95M-85.34%-77.91M
Net non-operating interest income expense -155.62%-3.01M-130.58%-1.91M-112.05%-868K0.98%21.16M-58.05%2.3M2.73%5.42M21.00%6.24M42.99%7.2M666.18%20.96M86.32%5.49M
Non-operating interest income -3.18%5.27M-5.32%5.95M-1.01%7.18M23.28%26.09M28.07%7.11M1.81%5.44M21.06%6.28M42.95%7.26M260.41%21.16M85.74%5.55M
Non-operating interest expense 35,913.04%8.28M17,362.22%7.86M14,538.18%8.05M2,269.71%4.93M7,528.57%4.81M-67.14%23K28.57%45K37.50%55K-93.37%208K46.51%63K
Other net income (expense) -959.38%-275K-581.40%-586K-154.02%-221K31.58%-247K-92.73%-106K148.48%32K7.53%-86K40.82%-87K-14.24%-361K48.11%-55K
Other non- operating income (expenses) -959.38%-275K-581.40%-586K-154.02%-221K31.58%-247K-92.73%-106K148.48%32K7.53%-86K40.82%-87K-14.24%-361K48.11%-55K
Income before tax 27.83%-60.72M-5.56%-71.85M-17.19%-84.85M-52.25%-318.76M-29.94%-94.17M-64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M
Income tax
Net income 27.83%-60.72M-5.56%-71.85M-17.19%-84.85M-52.25%-318.76M-29.94%-94.17M-64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M
Net income continuous Operations 27.83%-60.72M-5.56%-71.85M-17.19%-84.85M-52.25%-318.76M-29.94%-94.17M-64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M
Minority interest income
Net income attributable to the parent company 27.83%-60.72M-5.56%-71.85M-17.19%-84.85M-52.25%-318.76M-29.94%-94.17M-64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.83%-60.72M-5.56%-71.85M-17.19%-84.85M-52.25%-318.76M-29.94%-94.17M-64.48%-84.13M-52.56%-68.06M-76.04%-72.4M-40.19%-209.36M-84.91%-72.47M
Basic earnings per share 28.57%-0.7-3.75%-0.83-15.29%-0.98-24.83%-3.72-10.00%-1.1-34.25%-0.98-25.00%-0.8-44.07%-0.85-21.14%-2.98-61.29%-1
Diluted earnings per share 28.57%-0.7-3.75%-0.83-15.29%-0.98-24.83%-3.72-10.00%-1.1-34.25%-0.98-25.00%-0.8-44.07%-0.85-21.14%-2.98-61.29%-1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More